Cargando…
Intrauterine Bone Marrow Transplantation in Osteogenesis Imperfecta Mice Yields Donor Osteoclasts and Osteomacs but Not Osteoblasts
• The goal of osteogenesis imperfecta (OI) cell therapy is osteoblast replacement; • In utero transplantation (IUT) of bone marrow was conducted in OI mice; • Donor-derived osteoblasts were absent following bone marrow IUT; • Donor-derived hematopoietic cells included osteoclasts and osteal macropha...
Autores principales: | Millard, Susan M., Pettit, Allison R., Ellis, Rebecca, Chan, Jerry K.Y., Raggatt, Liza J., Khosrotehrani, Kiarash, Fisk, Nicholas M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649292/ https://www.ncbi.nlm.nih.gov/pubmed/26527386 http://dx.doi.org/10.1016/j.stemcr.2015.09.017 |
Ejemplares similares
-
Osteogenesis imperfecta
por: Vitturi, Bruno Kusznir, et al.
Publicado: (2018) -
Osteogenesis Imperfecta
por: Sam, Justin Easow, et al.
Publicado: (2017) -
Dentinogenesis imperfecta associated with osteogenesis imperfecta
por: Biria, Mina, et al.
Publicado: (2012) -
Management of Osteogenesis Imperfecta
por: Ralston, Stuart H., et al.
Publicado: (2020) -
4-Phenylbutyric acid enhances the mineralization of osteogenesis imperfecta iPSC-derived osteoblasts
por: Takeyari, Shinji, et al.
Publicado: (2020)